BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20768)

  • 21. [The immunoassay of IgM antibodies in samples clinically suspected of measles].
    Ribas Antúnez MA; Arocha Rosete Y; Toraño Canto I; Rodríguez Valdés C
    Rev Cubana Med Trop; 1998; 50(2):105-9. PubMed ID: 10349427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on the immunization effect of measles vaccine by capture-EIA].
    Fang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):297-9. PubMed ID: 1300252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.
    Ehrnst AC
    J Immunol; 1975 Mar; 114(3):1077-82. PubMed ID: 1089724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. II. Primary and secondary immunological response of experimental animals to attenuated and nonattenuated measles virus.
    Aleksandrowicz J; Polna I; Sadowski W
    Acta Microbiol Pol A; 1973; 5(3):139-45. PubMed ID: 4203633
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunoglobulins, antibodies and inhibitors of parainfluenza 3 virus in respiratory secretions of sheep.
    Smith WD; Wells PW; Burrells C; Dawson AM
    Arch Virol; 1975; 49(4):329-37. PubMed ID: 174528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemagglutination-inhibiting and neutralizing antibodies to type 3 and 5 rhinoviruses in human sera and nasal washings.
    Strízová V; Hrusková J; Syrücek L; Brücková M; Berkovicová V
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):348-52. PubMed ID: 231069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison between the plaque reduction neutralization test and the hemagglutination inhibition test in determination of human anti-measles antibodies].
    Kong J; Guo SH; Ze WY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):105-7. PubMed ID: 8758407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulins profile of measles.
    Gupta PC; Dutta AK; Khare S; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):780-4. PubMed ID: 2516012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral fluid, a substitute for serum to monitor measles IgG antibody?
    Goyal A; Shaikh NJ; Kinikar AA; Wairagkar NS
    Indian J Med Microbiol; 2009; 27(4):351-3. PubMed ID: 19736406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
    Glikmann G; Petersen I; Mordhorst CH
    Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines].
    Kuwajima S
    Hokkaido Igaku Zasshi; 1986 Jan; 61(1):5-14. PubMed ID: 3699682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gelatin particle agglutination (PA) antibody: comparison to neutralizing antibody (NT) and hemagglutination inhibition (HI) antibody and relationship to IgG avidity].
    Saika S; Matsunaga T; Ogawa T; Ichinohe S
    Kansenshogaku Zasshi; 2008 Jul; 82(4):310-6. PubMed ID: 18697482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus.
    Erdman DD; Anderson LJ; Adams DR; Stewart JA; Markowitz LE; Bellini WJ
    J Clin Microbiol; 1991 Jul; 29(7):1466-71. PubMed ID: 1885743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The physico-chemical nature of anti-measles antibodies in children who have had typical measles].
    Tikhonova NT; Khrometskaia TM; Kholchev NV; Strel'tsova MP; Nesterova TP
    Vopr Virusol; 1973; 18(1):27-32. PubMed ID: 4791702
    [No Abstract]   [Full Text] [Related]  

  • 38. Detection of IgG antibodies specific for measles virus by enzyme-linked immunosorbent assay (ELISA).
    Kahane S; Goldstein V; Sarov I
    Intervirology; 1979; 12(1):39-46. PubMed ID: 387655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles virus-specific IgM antibodies in sera from patients with chronic active hepatitis.
    Christie KE; Haukenes G
    J Med Virol; 1983; 12(4):267-72. PubMed ID: 6655465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term antibody response after measles vaccination in an isolated arctic society in Greenland.
    Pedersen IR; Mordhorst CH; Ewald T; von Magnus H
    Vaccine; 1986 Sep; 4(3):173-8. PubMed ID: 3532604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.